B. Metzler seel. Sohn & Co. Holding AG bought a new stake in CVS Health Co. (NYSE:CVS - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 61,838 shares of the pharmacy operator's stock, valued at approximately $3,888,000.
Other large investors have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory purchased a new position in CVS Health in the 3rd quarter worth $31,000. Crewe Advisors LLC bought a new stake in CVS Health in the first quarter worth $40,000. Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter valued at about $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the third quarter worth about $33,000. Hedge funds and other institutional investors own 80.66% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on CVS shares. Cantor Fitzgerald restated a "neutral" rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. TD Cowen upgraded shares of CVS Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Evercore ISI increased their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research report on Tuesday, October 8th. Truist Financial reaffirmed a "buy" rating and set a $67.00 price objective (down from $76.00) on shares of CVS Health in a research note on Wednesday. Finally, Royal Bank of Canada cut their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and an average target price of $72.28.
Check Out Our Latest Analysis on CVS
CVS Health Price Performance
CVS stock opened at $56.83 on Thursday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The firm has a 50 day moving average price of $59.18 and a 200-day moving average price of $58.61. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The firm has a market capitalization of $71.52 billion, a price-to-earnings ratio of 14.42, a PEG ratio of 0.94 and a beta of 0.55.
CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.21 earnings per share. Equities research analysts forecast that CVS Health Co. will post 5.43 EPS for the current fiscal year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.68%. CVS Health's dividend payout ratio is presently 67.51%.
About CVS Health
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
